1Dickstein K,Cohen-Solal A,Filippatos G. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008[J].European Heart Journal,2008.2388-2442.
3Worster A,Balion CM,Hill SA. Diagnostic accuracy of BNP and NT-pro BNP in patients presenting to acute care settings with dyspnea:A systematic review[J].Clinical Biochemistry,2008,(4/5):250-259.doi:10.1016/j.clinbiochem.2007.08.008.
8Nishiyama K,Tsutamoto T,Kawahara C. Relationship Between Biological Variation in B-Type Natriuretic Peptide and Plasma Renin Concentration in Stable Outpatients With Dilated Cardiomyopathy[J].Circulation,2011,(08):1897-1904.
9MAEDA K, TSUTAMOTA T, WADA A, et al. Plasma brain natriuretic peptide as a biochemical marker of high LVEF ventricular end-diastolic pressure in patients with symptomatic LVEF ventricular dysfunction[J]. Am Heart J, 1998, 135: 825-832.
10CHEN H H, BURNETT J C. Natriuretic peptides in the pathophysiology of congestive heart failure [J]. Curr Cardiol Rep, 2000, 2:198-205.
8Loke I,Squire IB,Davies JE,et al. Reference ranges for natriuret-ic peptide for diagnostic use are dependent on age, gender andheart ratel. Eur J Heart Fail,2003 ,5(5) :599-601.
9Iwanaga Y,Nishi I,Furuichi S,et al. B-type natriuretic peptidestrongly reflects diastolic wall stress in patients with chronic heartfailure : comparison between systolic and diastolic heart failure. JAm Coll Cardiol,2006,47(4) ;7422-7481.
10Tuinenburg AE, Brundel BJ. Gene expression of the natriureticpeptide sysem in atrial tissue of patients with paroxysmal and per-sistent atrial fibrillation. Jcardiovasc Electrophysiol, 2009, 10(6):827-835.
